Rai Services Company
lobbying client · lobbying firm
Rai Services Company's federal footprint — reported lobbying spend and, where matched, federal money received. Figures are as reported to the U.S. Senate (LDA) and USAspending.
Reported country: 🇺🇸 United States
Lobbying over time
| FY | Lobbying spend (as client) | Lobbying billed / handled (as firm) |
|---|---|---|
| 2022 | $4,910,040 | $2,590,000 |
| 2023 | $5,806,040 | $3,350,000 |
| 2024 | $7,864,040 | $5,660,000 |
| 2025 | $9,590,000 | $7,260,000 |
Two figures: what Rai Services Company reported spending on its own lobbying (as a client) and what it billed or handled for the clients it represents (as a firm — revenue, not its own spend). For a self-filer these overlap.
Firms hired
- Peter Damon Group LLC $1,740,000 · 29 filings
- Guidepoststrategies, LLC $1,100,000 · 16 filings
- Bgr Government Affairs $1,020,000 · 17 filings
- The Smith-Free Group, LLC $960,000 · 16 filings
- Rowland Strategy Group LLC $800,000 · 16 filings
- Hr Strategies LLC $630,000 · 16 filings
- Cgcn Group, LLC $600,000 · 12 filings
- Capitol Consulting Group LLC (Dc) $560,000 · 12 filings
- Greenberg Traurig, LLP $480,000 · 8 filings
- Hecht Latham Spencer & Associates, INC., Formerly Known As Hecht Spencer & Assoc $380,000 · 17 filings
Registrants that filed lobbying on behalf of Rai Services Company.
Clients represented
Self-filed — Rai Services Company registers and lobbies on its own behalf, with no separate outside clients.
Issues
| Issue area | Lobbied | Worked |
|---|---|---|
| Tobacco | 198 | 16 |
| Taxation/Internal Revenue Code | 101 | 16 |
| Trade (domestic/foreign) | 78 | 16 |
| Budget/Appropriations | 73 | 16 |
| Agriculture | 44 | 16 |
| Health Issues | 38 | — |
| Government Issues | 26 | 16 |
| Banking | 6 | — |
| Civil Rights/Civil Liberties | 4 | — |
| Law Enforcement/Crime/Criminal Justice | 4 | — |
| Consumer Issues/Safety/Products | 3 | — |
| Defense | 1 | — |
| Science/Technology | 1 | 1 |
Issue areas across Rai Services Company's filings, by activity count — as the client (Lobbied) and as the registrant/firm (Worked). Linked areas open the CivicGate issue page.
What they lobbied on
Reported activity from Senate LDA
-
FY2025 Agriculture as client
Tobacco
-
FY2025 Tobacco as client
educated members of congress on FDA processes
-
FY2025 Tobacco as client
Consumer choice in tobacco products.
-
FY2025 Tobacco as client
Consumer choice in tobacco products.
-
FY2025 Tobacco as client
Issues impacting the domestic tobacco industry.
-
FY2025 Budget/Appropriations as client
Appropriations.
-
FY2025 Trade (domestic/foreign) as client
International trade. Commerce issues.
-
FY2025 Tobacco as client
Implementation of P.L. 111-31, the Tobacco Control Act; Issues surrounding FDA PMTA and MRTP compliance policies; Issues surrounding tobacco harm reduction; Issues surrounding efforts to prevent youth access to tobacco products; Discussions in support of the regulation of products containing synthetic nicotine and disposable e-cigarettes.
Show 52 more activities
-
FY2025 Trade (domestic/foreign) as client
Issues surrounding prevention of illicit tobacco, patents, tariffs, duty and customs, Free Trade Agreements (FTAs).
-
FY2025 Taxation/Internal Revenue Code as client
Discussions concerning draft legislation to amend corporate tax rates and federal excise taxes on tobacco products; Issues surrounding taxation of tobacco products.
-
FY2025 Agriculture as client
Tobacco
-
FY2025 Tobacco self-filed
Implementation of P.L. 111-31, the Tobacco Control Act Issues surrounding FDA, PMTA, and MRTP compliance policies Issues surrounding tobacco harm reduction Issues surrounding efforts to prevent youth access to tobacco products Discussions in support of the regulation of products containing synthetic nicotine and disposable e-cigarettes Issues surrounding increased scrutiny on FDA/CTP for delayed enforcement Issues surrounding CBP resources for interdicting massive influx & mislabeling illicit vapes Issues surrounding retail inspections enforcement limitation Issues surrounding implementation of P.L. 111-31, the Tobacco Control Act NPRM for Docket No. FDA-2021-N-1349: Tobacco Product Standard for Menthol in Cigarettes January 2025 Proposed Rule: Tobacco Product Standard for Nicotine Yield of Cigarettes and Certain Other Combusted Tobacco Products Discussions regarding federal excise taxes and the taxation of tobacco products Discussions regarding FDA enforcement of flavored disposable e-cigarettes and PMTA transparency
-
FY2025 Trade (domestic/foreign) self-filed
Issues surrounding prevention of illicit tobacco, patents, tariffs, duty and customs, Free Trade Agreements (FTAs); H.R. 1, One Big Beautiful Bill Act
-
FY2025 Budget/Appropriations self-filed
Discussions concerning the FY 2025 and FY 2026 appropriations bills; provisions related to the FDA regulation of tobacco
-
FY2025 Agriculture self-filed
Issues related to the legalization and regulation of cannabidiol (CBD) Issues related to the legalization and regulation of cannabis
-
FY2025 Government Issues self-filed
Issues related to the legalization and regulation of cannabidiol (CBD) Issues related to the legalization and regulation of cannabis
-
FY2025 Taxation/Internal Revenue Code self-filed
S. 464, No Tax Subsidies for E-Cigarette and Tobacco Ads Act S. 2929/H.R. 5715, Tobacco Tax Equity Act Issues surrounding Internal Revenue Code 420 Discussions concerning the tax rate on corporate stock buybacks and U.S. multinationals foreign earnings Discussions concerning draft legislation to amend corporate tax rates and federal excise taxes/duties on tobacco products Discussions concerning a retaliatory tax on international companies from countries that adopt extraterritorial tax schemes. Issues surrounding taxation of tobacco products
-
FY2025 Agriculture self-filed
Issues related to the legalization and regulation of cannabidiol (CBD) Issues related to the legalization and regulation of cannabis
-
FY2025 Tobacco self-filed
Implementation of P.L. 111-31, the Tobacco Control Act Issues surrounding FDA, PMTA, and MRTP compliance policies Issues surrounding tobacco harm reduction Issues surrounding efforts to prevent youth access to tobacco products Discussions in support of the regulation of products containing synthetic nicotine and disposable e-cigarettes Issues surrounding increased scrutiny on FDA/CTP for delayed enforcement Issues surrounding CBP resources for interdicting massive influx & mislabeling illicit vapes Issues surrounding retail inspections enforcement limitation Issues surrounding implementation of P.L. 111-31, the Tobacco Control Act NPRM for Docket No. FDA-2021-N-1349: Tobacco Product Standard for Menthol in Cigarettes January 2025 Proposed Rule: Tobacco Product Standard for Nicotine Yield of Cigarettes and Certain Other Combusted Tobacco Products Discussions regarding federal excise taxes and the taxation of tobacco products Discussions regarding FDA enforcement of flavored disposable e-cigarettes and PMTA transparency
-
FY2025 Trade (domestic/foreign) self-filed
Issues surrounding prevention of illicit tobacco, patents, tariffs, duty and customs, Free Trade Agreements (FTAs)
-
FY2025 Budget/Appropriations self-filed
Discussions concerning the FY 2025 and FY 2026 appropriations bills; provisions related to the FDA regulation of tobacco H.R. 10545 - American Relief Act, 2025; provisions relating to FDA regulation of tobacco
H.R. 10545
-
FY2025 Government Issues self-filed
Issues related to the legalization and regulation of cannabidiol (CBD) Issues related to the legalization and regulation of cannabis
-
FY2025 Taxation/Internal Revenue Code self-filed
S. 464, No Tax Subsidies for E-Cigarette and Tobacco Ads Act S. 2929/H.R. 5715, Tobacco Tax Equity Act Issues surrounding Internal Revenue Code 420 Discussions concerning the tax rate on corporate stock buybacks and U.S. multinationals foreign earnings Discussions concerning draft legislation to amend corporate tax rates and federal excise taxes/duties on tobacco products Discussions concerning a retaliatory tax on international companies from countries that adopt extraterritorial tax schemes. Issues surrounding taxation of tobacco products
-
FY2025 Tobacco as client
Issues related to the regulation of the tobacco industry
-
FY2025 Tobacco as client
Issues surrounding tobacco harm reduction; Discussions regarding federal excise taxes and taxation of tobacco products; Issues surrounding efforts to prevent youth access to tobacco products; Discussions in support of the regulation of products containing synthetic nicotine; ANPRMs for Docket Nos. FDA-2017-N-6189 and FDA-2017-N-6565; NPRM for Docket No. FDA-2021-N-1349 Tobacco Product Standard for Menthol in Cigarettes; Issues surrounding upcoming proposed rule on Tobacco Product Standard for Nicotine Level of Certain Tobacco Products.
-
FY2025 Taxation/Internal Revenue Code as client
Discussions concerning draft legislation to amend corporate tax rates, federal excise taxes on tobacco products, and taxation of synthetic nicotine; Tobacco Tax Equity Act.
-
FY2025 Trade (domestic/foreign) as client
Issues surrounding prevention of illicit tobacco.
-
FY2025 Tobacco as client
Implementation of P.L. 111-31, the Tobacco Control Act Issues surrounding FDA PMTA and MRTP compliance policies Issues surrounding tobacco harm reduction Issues surrounding efforts to prevent youth access to tobacco products Discussions in support of the regulation of products containing synthetic nicotine and disposable e-cigarettes Issues surrounding increased scrutiny on FDA/CTP for delayed enforcement Issues surrounding CBP resources for interdicting massive influx & mislabeling illicit vapes Issues surrounding retail inspections enforcement limitation Issues surrounding implementation of P.L. 111-31, the Tobacco Control Act NPRM for Docket No. FDA-2021-N-1349: Tobacco Product Standard for Menthol in Cigarettes January 2025 Proposed Rule: Tobacco Product Standard for Nicotine Yield of Cigarettes and Certain Other Combusted Tobacco Products Issues surrounding efforts to prevent youth access to tobacco products Discussions regarding federal excise taxes and the taxation of tobacco products Discussions regarding FDA enforcement of flavored disposable e-cigarettes and PMTA transparency
-
FY2025 Trade (domestic/foreign) as client
Issues surrounding prevention of illicit tobacco, patents, tariffs, duty and customs, Free Trade Agreements (FTAs); HR 1, THE ONE BIG BEAUTIFUL BILL
-
FY2025 Taxation/Internal Revenue Code as client
S. 464, No Tax Subsidies for E-Cigarette and Tobacco Ads Act S. 2929/H.R. 5715, Tobacco Tax Equity Act Issues surrounding Internal Revenue Code 420 Discussions concerning the tax rate on corporate stock buybacks and U.S. multinationals foreign earnings Discussions concerning draft legislation to amend corporate tax rates and federal excise taxes/duties on tobacco products Discussions concerning a retaliatory tax on international companies from countries that adopt extraterritorial tax schemes. Issues surrounding taxation of tobacco products
-
FY2025 Budget/Appropriations as client
Discussions concerning the FY 2025 and FY 2026 appropriations bills; provisions related to the FDA regulation of tobacco.
-
FY2025 Taxation/Internal Revenue Code as client
Monitored discussions involving taxation of tobacco products Monitored discussions involving international taxation Monitored discussions involving taxation of nicotine
-
FY2025 Tobacco as client
Discussions involving regulation of disposable vaping products Discussions involving the regulation of menthol and other flavors Discussions involving illicit Chinese vapor products Monitored discussions related to Very Low Nicotine regulations Monitored Food and Drug Administration activity on modified risk product applications Monitored executive branch nominations to federal agencies and commissions
-
FY2025 Trade (domestic/foreign) as client
Discussions regarding tariffs and duty drawback on tobacco products
-
FY2025 Taxation/Internal Revenue Code as client
Tax treatment of pension assets.
-
FY2025 Agriculture self-filed
Issues related to the legalization and regulation of cannabidiol (CBD) Issues related to the legalization and regulation of cannabis
-
FY2025 Government Issues self-filed
Issues related to the legalization and regulation of cannabidiol (CBD) Issues related to the legalization and regulation of cannabis
-
FY2025 Tobacco self-filed
Implementation of P.L. 111-31, the Tobacco Control Act Issues surrounding FDA, PMTA, and MRTP compliance policies Issues surrounding tobacco harm reduction Issues surrounding efforts to prevent youth access to tobacco products Discussions in support of the regulation of products containing synthetic nicotine and disposable e-cigarettes Issues surrounding FDA/CTP enforcement actions Issues surrounding implementation of P.L. 111-31, the Tobacco Control Act NPRM for Docket No. FDA-2021-N-1349: Tobacco Product Standard for Menthol in Cigarettes January 2025 Proposed Rule: Tobacco Product Standard for Nicotine Yield of Cigarettes and Certain Other Combusted Tobacco Products Discussions regarding federal excise taxes and the taxation of tobacco products Discussions regarding FDA enforcement of flavored disposable e-cigarettes and PMTA transparency
-
FY2025 Trade (domestic/foreign) self-filed
Issues surrounding prevention of illicit tobacco, patents, tariffs, duty and customs, Free Trade Agreements (FTAs); H.R. 1, One Big Beautiful Bill Act
-
FY2025 Budget/Appropriations self-filed
Discussions concerning the FY 2025 and FY 2026 appropriations bills; provisions related to the FDA regulation of tobacco
-
FY2025 Taxation/Internal Revenue Code self-filed
S. 464, No Tax Subsidies for E-Cigarette and Tobacco Ads Act S. 2929/H.R. 5715, Tobacco Tax Equity Act Issues surrounding Internal Revenue Code 420 Discussions concerning the tax rate on corporate stock buybacks and U.S. multinationals foreign earnings Discussions concerning draft legislation to amend corporate tax rates and federal excise taxes/duties on tobacco products Discussions concerning a retaliatory tax on international companies from countries that adopt extraterritorial tax schemes Issues surrounding taxation of tobacco products
-
FY2025 Budget/Appropriations as client
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2025 - Title VII - Food and Drug Administration - Section 733 - provisions related to federal regulation of tobacco (P.L. 119 - 4, March 15, 2025).
-
FY2025 Tobacco as client
P.L. 111-31 - Family Smoking Prevention and Tobacco Control and Federal Retirement Reform Act - implementation of provisions relating to regulation of tobacco; 81 FR 289783 (May 10, 2016) - implementation of Food and Drug Administration final rule deeming certain tobacco products, including electronic cigarettes, as subject to FDA regulation; Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2025 - Title VII - Food and Drug Administration - Section 733 - provisions related to federal regulation of tobacco (P.L. 119 - 4, March 15, 2025).
-
FY2025 Health Issues as client
P.L. 111-31 - Family Smoking Prevention and Tobacco Control and Federal Retirement Reform Act - implementation of provisions relating to regulation of tobacco; 81 FR 289783 (May 10, 2016) - implementation of Food and Drug Administration final rule deeming certain tobacco products, including electronic cigarettes, as subject to FDA regulation.
-
FY2025 Taxation/Internal Revenue Code as client
Issues relating to tobacco excise taxes.
-
FY2025 Tobacco as client
Tobacco harm reduction
-
FY2025 Government Issues as client
Tobacco harm reduction and illicit sales of cigarettes
-
FY2025 Tobacco as client
P.L. 111-31 - Family Smoking Prevention and Tobacco Control and Federal Retirement Reform Act - implementation of provisions relating to regulation of tobacco; 81 FR 289783 (May 10, 2016) - implementation of Food and Drug Administration final rule deeming certain tobacco products, including electronic cigarettes, as subject to FDA regulation; Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026 - Title VII - Food and Drug Administration - Section 733 - provisions related to federal regulation of tobacco.
-
FY2025 Health Issues as client
P.L. 111-31 - Family Smoking Prevention and Tobacco Control and Federal Retirement Reform Act - implementation of provisions relating to regulation of tobacco; 81 FR 289783 (May 10, 2016) - implementation of Food and Drug Administration final rule deeming certain tobacco products, including electronic cigarettes, as subject to FDA regulation.
-
FY2025 Taxation/Internal Revenue Code as client
H.R. 1 - One Big Beautiful Bill Act - Section 112032 - Limitation on Drawback of Taxes Paid with Respect to Substituted Merchandise - entire House provision.
-
FY2025 Budget/Appropriations as client
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026 - Title VII - Food and Drug Administration - Section 733 - provisions related to federal regulation of tobacco.
-
FY2025 Tobacco as client
Issues related to the regulation of the tobacco industry
-
FY2025 Taxation/Internal Revenue Code as client
Tax treatment of pension assets.
-
FY2025 Tobacco as client
Provide monitoring, analysis, advise and support services related to legislative and administrative policies impacting the tobacco industry
-
FY2025 Tobacco as client
Provide monitoring, analysis, advise and support services related to legislative and administrative policies impacting the tobacco industry
-
FY2025 Tobacco as client
Consumer choice in tobacco products.
-
FY2025 Tobacco as client
Provide monitoring, analysis, advise and support services related to legislative and administrative policies impacting the tobacco industry
-
FY2025 Tobacco as client
Consumer choice in tobacco products.
-
FY2025 Tobacco as client
educated members of congress on FDA processes
-
FY2025 Agriculture as client
Discussions regarding the Fiscal Year 2025 appropriations for the Food and Drug Administration
The specific issues and bills Rai Services Company reported lobbying on, newest first. Bill references that CivicGate tracks link to the bill; others are shown as reported.